|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1648 SEK | +1.10% |
|
+3.26% | -32.87% |
| Feb. 23 | Abliva AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
| 2023 | Abliva AB Reaches Patient Enrollment Goal for Wave 1 of the FALCON Study | CI |
Abliva AB (publ) reported earnings results for the fourth quarter ended December 31, 2021. For the fourth quarter, the company reported sales was SEK 0.048 million compared to SEK 0.112 million a year ago. Revenue was SEK 0.174 million compared to SEK 1.74 million a year ago.
Net loss was SEK 36.87 million compared to SEK 13.06 million a year ago. Basic loss per share from continuing operations was SEK 0.09. Diluted loss per share from continuing operations was SEK 0.09.
| 1st Jan change | Capi. | |
|---|---|---|
| -32.87% | 20.28M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.73B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
ABLIVA AB 
